Fundraising Fox

Akadeum Life Sciences

Ann Arbor, US · Founded 2014 · Delaware corporation · 12 known investors

akadeum.com ↗

Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.

Advanced ManufacturingBiotechDeep TechHealthtechMedical Devices

Founders & leadership

Akadeum Life Sciences was founded in 2014 by Kalyan Handique and John Younger.

KH
Kalyan HandiqueCo-founder
JY
John YoungerCo-founder
JM
James MilitelloExecutive

Board

JS
Jeffrey S. WilliamsBoard director
PD
Paul D'AmatoBoard director
DKDan Kidle
Dan KidleinBoard MemberManaging Partner at Arboretum Ventures
BM
Brandon McNaughtonBoard directorAdvisor to the Fund at Kern Venture Group
JLJenni Li
Jenni LiinBoard directorSenior Principal at Michigan Capital Network
DNDouglas Neal
Douglas NealinBoard Observer2014–2025Managing Director at eLab Ventures

Investors · 12

Arboretum VenturesAnn Arbor · $5M – $15M
BeringeaLondon · $3M – $10M
Berkeley CatalystBerkeley
BlueStone Venture PartnersTucson · $250K – $1M
eLab VenturesAnn Arbor · $25K – $100K
ID VenturesDetroit · $50K – $250K
Invest MichiganNorthville · $100K – $250K
Kern Venture GroupBakersfield
Michigan Capital NetworkGrand Rapidsvia Jenni Li · board
Michigan RiseEast Lansing · $50K – $150K
NYBC VenturesNew York
Western Technology InvestmentPortola Valley · $250K – $30M

Reported raises · per SEC filings

Form D private placements

$17.6M disclosed across 8 rounds · 2014–2026

▶$2.1MraisedJul 2026 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kalyan HandiqueExecutive Officer, Director
  • Paul D'AmatoDirector
  • Jenni LiDirector
  • James MilitelloExecutive Officer
Offering amount
$3.4M
Amount sold
$2.1M
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.6MraisedApr 2025 · 35 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey S. WilliamsDirector
  • Paul D'AmatoDirector
  • Dan KidleDirector
  • Brandon McNaughtonExecutive Officer, Director
  • James MilitelloExecutive Officer
Offering amount
$7.2M
Amount sold
$5.6M
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedMay 2023 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William HyunDirector
  • Brandon McNaughtonExecutive Officer, Director
  • Dan KidleDirector
  • George DunbarDirector
  • John GavenonisDirector
Offering amount
$6.5M
Amount sold
$6M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$900KraisedNov 2018 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon McNaughtonExecutive Officer, Director
  • John YoungerExecutive Officer, Director
  • Brock SiegelDirector
  • Douglas NealDirector
Offering amount
$2M
Amount sold
$900K
Minimum investment
$25K
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedAug 2017 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul BrownDirector
  • John YoungerExecutive Officer, Director
  • Brandon McNaughtonExecutive Officer, Director
  • William WoodDirector
  • Douglas NealDirector
Offering amount
$1.6M
Amount sold
$1.5M
First sale
Jul 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$360KraisedDec 2016 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John YoungerExecutive Officer, Director
  • Douglas NealDirector
  • Brandon McNaughtonExecutive Officer, Director
Offering amount
$1M
Amount sold
$360K
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$905.1KraisedAug 2015 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brandon McNaughtonExecutive Officer, Director
  • Douglas NealDirector
  • John YoungerExecutive Officer, Director
Offering amount
$1M
Amount sold
$905.1K
First sale
May 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedOct 2014 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John YoungerExecutive Officer, Director
  • Brandon McNaughtonExecutive Officer, Director
Offering amount
$150K
Amount sold
$150K
First sale
Oct 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Osmosis1901 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
BYJU'S1664 shared keywordsBYJU'S offers online learning programs, video lessons, and a personalized learning app for students in India, including tutoring and exam-preparation programs for competitive tests such as JEE and NEET.

Companies competing with Akadeum Life Sciences for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Akadeum secures $20m to advance cell separation platformbioprocessintl.com · Jun 2025Akadeum Life Sciences Lands Major Investment to Fuel Growth in Cell and Gene Therapy - BioSpacebiospace.com · Jun 2025Akadeum Life Sciences Raises $20M+ in Fundingfinsmes.com · Jun 2025Akadeum Raises $17.5M Financing Round Led by Arboretum Venturesakadeum.com · Oct 2021Akadeum Series A Funding Round - Akadeum Life Sciencesakadeum.com · Dec 2019

Frequently asked questions

What does Akadeum Life Sciences do?
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
Who founded Akadeum Life Sciences?
Akadeum Life Sciences was founded by Kalyan Handique, John Younger in 2014.
Who are Akadeum Life Sciences's investors?
Akadeum Life Sciences's investors include Arboretum Ventures, Beringea, Berkeley Catalyst, BlueStone Venture Partners, eLab Ventures, ID Ventures, Invest Michigan, Kern Venture Group and 4 more.
How much funding has Akadeum Life Sciences raised?
Akadeum Life Sciences has disclosed $17.6M raised across 8 rounds.
Where is Akadeum Life Sciences headquartered?
Akadeum Life Sciences is headquartered in Ann Arbor, US.